Author

J. F. Cavallari

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Physiology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:mouse· 3 Research Focus:cell signaling & trafficking· 2 Research Focus:metabolism & bioenergetics· 2 Assay:proteomics· 1

Frequent Co-Authors

B. D. Henriksbo· 2 shared B. M. Duggan· 2 shared F. F. Anhe· 2 shared J. D. Schertzer· 2 shared K. P. Foley· 2 shared N. G. Barra· 2 shared C. Y. Chen· 1 shared J. Schertzer· 1 shared

Activity by Year

2020-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPhysiology

B. D. Henriksbo

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Metabolic endotoxemia is dictated by the type of lipopolysaccharide

F. F. Anhe, N. G. Barra, J. F. Cavallari, B. D. Henriksbo, J. Schertzer

The paper shows that the type of lipopolysaccharide (LPS) determines metabolic endotoxemia effects, with E. coli LPS causing dysglycemia and inflammation while R. sphaeroides LPS has beneficial effects.

bioRxiv · Jul 13, 2021Physiology

Gut microbiota impairs insulin clearance during obesity

K. P. Foley, S. Zlitni, B. M. Duggan, N. Barra, F. F. Anhe, J. F. Cavallari, B. D. Henriksbo, C. Y. Chen, M. Huang, T. Lau, J. D. Schertzer

This study shows that gut microbiota impair insulin clearance during obesity, with specific bacterial taxa linked to this effect, suggesting potential therapeutic targets.

bioRxiv · May 8, 2020 · PreprintPhysiology

RIPK2 dictates insulin responses to tyrosine kinase inhibitors in obese mice

B. M. Duggan, J. F. Cavallari, K. P. Foley, N. G. Barra, J. D. Schertzer

This study shows that RIPK2 limits the insulin sensitizing effect of gefitinib, while imatinib increases insulin secretion in obese mice, indicating TKI actions on RIPK2 dictate divergent insulin responses.

bioRxiv · Apr 3, 2020Physiology